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 ʹ
Abstract ͳ͹
 ͳͺ
Accurate typing methods are required for efficient infection control. The emergence ͳͻ
of whole genome sequencing (WGS) technologies has enabled the development of ʹͲ
genomics-based methods applicable for routine typing and surveillance of bacterial ʹͳ
pathogens. In this study, we developed the Pseudomonas aeruginosa serotyper ʹʹ
(PAst) program, which enabled in silico serotyping of P. aeruginosa isolates using ʹ͵
WGS data. PAst has been made publically available as a web-service, and aptly ʹͶ
facilitate high-throughput serotyping analysis. The program overcomes critical issues ʹͷ
such as the loss of in vitro typeability often associated with P. aeruginosa isolates ʹ͸
from chronic infections, and quickly determines the serogroup of an isolate based on ʹ͹
the sequence of the O-specific antigen (OSA) gene cluster. Here, PAst analysis of ʹͺ
1649 genomes resulted in successful serogroup assignments in 99.27% of the cases. ʹͻ
This frequency is rarely achievable by conventional serotyping methods. The limited ͵Ͳ
number of non-typeable isolates found using PAst was the result of either complete ͵ͳ
absence of OSA genes in the genomes or the artifact of genomic misassembly. With ͵ʹ
PAst, P. aeruginosa serotype data can be obtained from WGS information alone. ͵͵
PAst is a highly efficient alternative to conventional serotyping methods in relation ͵Ͷ
to outbreak surveillance of serotype O12 and other high-risk clones, while ͵ͷ
maintaining backward compatibility to historical serotype data. ͵͸
  ͵͹
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 ͵
Introduction ͵ͺ
 ͵ͻ
Pseudomonas aeruginosa is a Gram-negative opportunistic pathogen and a major ͶͲ
cause of mortality and morbidity among hospitalized and compromised patients Ͷͳ
including those with cystic fibrosis (CF). P. aeruginosa is well known for its ability to Ͷʹ
cause chronic and extensively drug resistant infections (1). The outer membrane Ͷ͵
lipopolysaccharide (LPS) layer is a major virulence factor of P. aeruginosa (2). LPS has ͶͶ
been linked to antibiotic resistance and immune evasion. Furthermore, LPS is one of Ͷͷ
the receptors that determines susceptibility of the bacterium to bacteriophages and Ͷ͸
pyocins (2–4). Our ability to control P. aeruginosa infections depends on the Ͷ͹
availability of accurate typing methods. Previously, serotyping was a benchmark Ͷͺ
typing method for P. aeruginosa. In the 1980’s the International Antigenic Typing Ͷͻ
Scheme (IATS) was established to classify the species P. aeruginosa into 20 serotypes ͷͲ
(O1-O20) (5–7). Today, serotyping is infrequently used in the clinic for typing ͷͳ
purposes, mainly because of the time consuming protocol, the need for a continuous ͷʹ
supply of serotype-specific antisera, and a high prevalence of polyagglutinating or ͷ͵
non-typeable isolates.  ͷͶ
 ͷͷ
The loss of P. aeruginosa typeability has been known for decades, and has often ͷ͸
been linked to bacteria isolated from chronic infections, where typeability is lost ͷ͹
over time during the course of infection (8, 9). A study performed by Pirnay et al (10) ͷͺ
showed that 65% of all P. aeruginosa isolates examined were either non- or multi-ͷͻ
typeable and therefore assigning a particular serotype to these strains would be ͸Ͳ
difficult. The occurrence of these non- or multi-typeable isolates was higher when ͸ͳ
evaluating isolates sampled exclusively from CF infections (10). Multi-typeability has ͸ʹ
been associated with poor prognosis for CF patients, and is a trait of persistent or ͸͵
chronic infection. This correlates with the observation that P. aeruginosa isolates ͸Ͷ
from chronic CF infections are initially resistant to human serum but evolve to ͸ͷ
becoming serum sensitive over time. This is likely due to the loss of production of O-͸͸
antigen, which protects the bacterial cell from the human serum (8). The mechanism ͸͹
underlying loss of typeability over time is not fully understood, but is most likely due ͸ͺ
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 Ͷ
to modifications of LPS structures over extended periods of bacteria-host ͸ͻ
interactions as a means to improve fitness in the host and to evade host immune ͹Ͳ
system, bacteriophages and antibiotic therapy.  ͹ͳ
 ͹ʹ
The knowledge concerning the serotype of an isolate is important for monitoring ͹͵
outbreaks and for understanding the structures of the LPS expressed on the surface ͹Ͷ
of these bacteria. O11 and O12 are more predominant than other serotypes in the ͹ͷ
clinic, and intriguingly, these serotypes have been associated with multi-drug ͹͸
resistance (MDR) (10–13). This implies that these particular LPS structures improve ͹͹
fitness within the hosts and the hospital environments in ways that we currently do ͹ͺ
not understand. Specifically for the O12 serotype, it has been shown that horizontal ͹ͻ
gene transfer of LPS genes has resulted in MDR isolates and the switching of a ͺͲ
certain serotype to O12 (14). To continuously monitor LPS structure and evolution, ͺͳ
serotyping can help to improve our understanding of the isolates that successfully ͺʹ
infect patients. The continued collection of these data will also enable retrospective ͺ͵
population analysis, as serotype has been recorded for decades also prior to the ͺͶ
emergence of other DNA-based typing methods such as MLST and PCR.  ͺͷ
 ͺ͸
P. aeruginosa LPS is comprised of three domains: lipid A, core oligosaccharide, and ͺ͹
O-antigen (2). Most P. aeruginosa isolates produce two forms of O-antigen ͺͺ
simultaneously: common polysaccharide antigen (CPA) and O-specific antigen (OSA). ͺͻ
While CPA is relatively conserved, OSA is variable and defines the serotype of an ͻͲ
isolate (2, 15). OSA is encoded in a gene cluster varying in size from just under 15 kb ͻͳ
to over 25 kb. The OSA gene cluster is flanked by the genes ihfB/himD and wbpM. ͻʹ
The 20 serotypes harbor 11 distinct OSA gene clusters, each with a high number of ͻ͵
unique genes (16). With the emergence of whole genome sequencing (WGS) ͻͶ
methods it is now possible to assign an isolate into one of 11 serogroups based on ͻͷ
the sequence and structure of the OSA gene cluster (11, 14, 17).  ͻ͸
 ͻ͹
The present study presents a program that our group has developed for fast and ͻͺ
reliable in silico serotyping of P. aeruginosa isolates using WGS data – the ͻͻ
Pseudomonas aeruginosa serotyper (PAst). The program has been made publically ͳͲͲ
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 ͷ
available as a web-service, and can enable high throughput serotyping analysis based ͳͲͳ
on analysis of the OSA gene cluster. Using PAst, issues with typeability of clinical ͳͲʹ
isolates can be overcome, and serotyping can be performed in a rapid and cost-ͳͲ͵
effective way in the clinic as whole genome sequencing of isolates become ͳͲͶ
accessible.   ͳͲͷ
  ͳͲ͸
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Materials and Methods ͳͲ͹
 ͳͲͺ
PAst verification and isolates included in the study ͳͲͻ
To evaluate the efficiency of the in silico serotyping using PAst, all available P. ͳͳͲ
aeruginosa genomes were acquired and analyzed. These P. aeruginosa genomes ͳͳͳ
were downloaded from NCBI and included 1120 genome assemblies (Supplementary ͳͳʹ
Table 1, extracted 18.08.2015). An exclusively CF-related P. aeruginosa dataset was ͳͳ͵
constructed, due mainly to the documented high level of non-typeability in ͳͳͶ
persistent infecting clones. The isolates described by Marvig et al. 2015 (475 ͳͳͷ
genomes) (18) were used as the initial dataset. These were assembled using SPAdes ͳͳ͸
(19) prior to analysis. Additional CF isolates were recovered by searching for P. ͳͳ͹
aeruginosa genome assemblies related to CF in PATRIC (54 genomes) (20). It was ͳͳͺ
verified that frequently observed CF-specific strains such as DK2 and LES were part of ͳͳͻ
the dataset. The final dataset included 529 CF-related P. aeruginosa genome ͳʹͲ
assemblies. In silico serotyping of both datasets was performed using PAst in order ͳʹͳ
to evaluate typeability of the program. Non-typeable isolates (i.e., isolates in which ͳʹʹ
%coverage of reference OSA was < 95%) were manually examined for either ͳʹ͵
biological or technical explanations of the lack of typeability. ͳʹͶ
 ͳʹͷ
PAst specifications ͳʹ͸
The PAst program is developed using the programming language Perl for in silico ͳʹ͹
serotyping of P. aeruginosa isolates using WGS data. It is based on a BLASTn analysis ͳʹͺ
of the assembled input genome, against an OSA cluster database. OSA clusters with ͳʹͻ
> 95% coverage in the query genome represents a positive hit for a serogroup. Since ͳ͵Ͳ
P. aeruginosa isolates have been described which either harbor multiple OSA ͳ͵ͳ
clusters or no clusters at all, the program accommodates multi-, mono- and non-ͳ͵ʹ
typeability based on analysis of the number of positive OSA hits and coverage (Figure ͳ͵͵
1). Compared to other studies (11, 14, 17) PAst optimizes in silico serotyping further ͳ͵Ͷ
by distinguishing members of the O2 serogroup through identification of the ͳ͵ͷ
acquired phage-related wzyɴ within serotypes O2 and O16 (21, 22). This enables ͳ͵͸
typing into 12 serogroups as opposed to the 11 described by Raymond et al. (16). ͳ͵͹
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 ͹
Together with a summary of the best hit(s) from the analysis and the BLAST report, ͳ͵ͺ
the user receives a multi fasta file containing the sequence(s) of the OSA cluster ͳ͵ͻ
from the analyzed isolate for use in future analysis. ͳͶͲ
 ͳͶͳ
The P. aeruginosa OSA cluster database ͳͶʹ
The database was constructed using the WGS data of the 20 P. aeruginosa IATS ͳͶ͵
serotype reference isolates (14). The genomes were assembled using SPAdes (19) ͳͶͶ
and the OSA clusters extracted via identification of the ihfB/himD gene flanking the ͳͶͷ
cluster upstream and the wbpM gene flanking the cluster downstream. The clusters ͳͶ͸
were aligned within their serotypes, described by Raymond et al. 2002 and their ͳͶ͹
shared structure confirmed (16). A representative cluster of each serotype was ͳͶͺ
selected for the database (Table 1). Also included in the database was the wzyɴ gene ͳͶͻ
for distinguishing the O2 and O5 serotypes, as the two serogroups share OSA cluster ͳͷͲ
organization, but only the O2 and O16 serotype harbor the wzyɴ gene present on a ͳͷͳ
prophage. ͳͷʹ
 ͳͷ͵
In silico serotyping of P. aeruginosa isolates using PAst ͳͷͶ
PAst has been implemented as a simple and user-friendly web-tool available on the ͳͷͷ
Center for Genomic Epidemiology (CGE) service platform ͳͷ͸
(https://cge.cbs.dtu.dk/services/PAst-1.0/). The tool accommodates raw reads, draft ͳͷ͹
assemblies (contigs or scaffolds) and complete genomes from all WGS platforms. ͳͷͺ
Raw read data are processed and assembled as previously described for other CGE ͳͷͻ
tools (23). Following analysis of the input data, the web-tool outputs the predicted ͳ͸Ͳ
serogroup of the query genome, the %coverage of the reference OSA cluster, as well ͳ͸ͳ
as the OSA cluster sequence in multi fasta format, for the user to continue exploring ͳ͸ʹ
the OSA genes (Fig. 1). If multiple positive hits are found (multi-typeability), all the ͳ͸͵
identified OSA clusters are written for the user (Fig. 1). In the case of a non-typeable ͳ͸Ͷ
query genome (where no OSA cluster has >95% coverage) the best hit identified is ͳ͸ͷ
written for the user together with the sequence of this hit (Fig. 1). ͳ͸͸
For batch analysis of larger datasets (only applicable for assembled genomes) the ͳ͸͹
PAst Perl program has been made available on Github: ͳ͸ͺ
https://github.com/Sandramses/PAst   ͳ͸ͻ
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 ͺ
Results ͳ͹Ͳ
The PAst web server tool  and analyzes the nucleotide sequence of the O-ͳ͹ͳ
specific antigen (OSA) gene cluster within the provided genomes and place them into ͳ͹ʹ
one of twelve serogroups defined in Table 1. These serogroups are defined by ͳ͹͵
sequence similarities between the 20 IATS serotypes (16) as well as ͳ͹Ͷ
absence/presence of the discriminatory wzyɴ gene (21, 22) and are as such different ͳ͹ͷ
from previously groupings of serotypes on the basis of in vitro serotyping data (11, ͳ͹͸
14, 17). All serogroups contained three or less of the 20 IATS serotypes (Table 1).  ͳ͹͹
 ͳ͹ͺ
More than 97% of the P. aeruginosa dataset is typeable using PAst ͳ͹ͻ
To evaluate the typeability efficiency of PAst all P. aeruginosa genome assemblies ͳͺͲ
available in NCBI (1120 genomes on date of extraction) were analyzed. A total of ͳͺͳ
97.68% (1094) of the 1120 genomes were typed unambiguously to a single ͳͺʹ
serogroup by PAst (Fig. 2). This means that each genome assembly had a single ͳͺ͵
BLAST hit of >95% OSA coverage to one sequence in our reference OSA database ͳͺͶ
(Fig. 2). No isolates were found to be multi-typeable and 2.32% (26 genomes) of the ͳͺͷ
1120 genomes were found to be non-typeable (Fig. 2). In these cases, no significant ͳͺ͸
BLAST hit of >95% OSA coverage to one of the sequence in the reference OSA ͳͺ͹
database was identified. PAst correctly determined the serogroup of the 20 IATS ͳͺͺ
strains as well as PAO1 (serotype O5), PA14 (serotype O10), and PAK (serotype O6).  ͳͺͻ
 ͳͻͲ
The analysis showed that all serogroups were represented in the 1120 genomes (Fig. ͳͻͳ
2). Four of the 12 serogroups represented 70% of the genomes analyzed; these were ͳͻʹ
O3, O6, O11 and O12 (Fig. 2).  The smallest serogroup was O13, which contained ͳͻ͵
only four genomes. We note that the same clone type could be present multiple ͳͻͶ
times in the dataset, and that a substantial sampling bias would therefore be ͳͻͷ
expected. The distribution of serotypes in our analysis thus describes what has been ͳͻ͸
chosen for sequencing and does not necessarily match the distribution of serotypes ͳͻ͹
in the actual P. aeruginosa population. This does not affect the high confidence of ͳͻͺ
PAst, as it shows that un-ambiguous typing of multiple isolates from the same ͳͻͻ
lineage is possible. ʹͲͲ
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 ͻ
 ʹͲͳ
PAst overcomes non-typeability issues from in vitro typing of CF lineages ʹͲʹ
P. aeruginosa isolates from CF infections are often non-typeable with conventional ʹͲ͵
serotyping assays. To explore if our genomics-based method could enable ʹͲͶ
acquisition of serotype information in such isolates, we analyzed 529 genome ʹͲͷ
assemblies of P. aeruginosa isolates sampled from CF infections. This dataset ʹͲ͸
contained multiple examples of isolates of the same lineage that had been sampled ʹͲ͹
during the course of infection. This enabled us to investigate whether in silico ʹͲͺ
typeability might be lost over time as has frequently been observed for in vitro ʹͲͻ
serotyping of isolates from chronic CF infections. Interestingly, 99.81% of the ʹͳͲ
genomes in the CF-specific dataset could be typed to single serogroups. More ʹͳͳ
importantly, no multi-typeable isolates were observed and only one isolate was ʹͳʹ
deemed non-typeable (Fig. 3). All serogroups were represented in the dataset, ʹͳ͵
except for O12. The absence of O12 serotypes among CF isolates has previously been ʹͳͶ
reported (10). Serotypes O1, O6 and O7/O8 represented ~65% of the CF-specific ʹͳͷ
dataset and the smallest representation of serotypes was the O9 serogroups with ʹͳ͸
only two isolates from these samples (Fig. 3).  ʹͳ͹
 ʹͳͺ
Well-known transmissible CF-specific clone types such as P. aeruginosa DK1 (24), ʹͳͻ
DK2 (25), and LES (26) are represented in the dataset due to multiple isolates being ʹʹͲ
sampled from various patients over several decades. Using our PAst tool, the typing ʹʹͳ
problems documented from in vitro typing of such lineages were not observed, and ʹʹʹ
the DK1, DK2 and LES isolates were consistently in silico serotyped with PAst. DK1 ʹʹ͵
and DK2 were found to belong to the O3 serogroup, while the LES lineage belonged ʹʹͶ
to the O6 serogroup. ʹʹͷ
 ʹʹ͸
Complete loss of O-specific antigen defining genes is a rare event ʹʹ͹
Out of two WGS-based datasets (n = 1649) that were in silico typed with PAst, our ʹʹͺ
results yielded a total of 27 non-typeable isolates. The lack of typeability in these 27 ʹʹͻ
genome assemblies was further investigated to resolve whether non-typeability in ʹ͵Ͳ
these cases was due to technical or biological reasons. We found that the %OSA ʹ͵ͳ
coverage of the non-typeable isolates ranged from a minimum of 1.91% to a ʹ͵ʹ
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 ͳͲ
maximum 93.96% OSA coverage (Supplementary Table 2). Of the 27 isolates ʹ͵͵
classified as non-typeable, thirteen were found to have OSA coverage of 0-20%, ʹ͵Ͷ
whereas seven isolates had OSA coverage of 80-95% (Fig. 4). The best hit (serogroup) ʹ͵ͷ
for each of the non-typeable isolates was then examined to evaluate if certain ʹ͵͸
serogroups were more prone to be problematic in the PAst analysis and why. The 27 ʹ͵͹
isolates were found to distribute across 6 serogroups (O1, O2, O6, O7, O11 and O13), ʹ͵ͺ
while 15/27 isolates showed a best hit to be typed as the O11 serogroup (Fig. 4).  ʹ͵ͻ
 ʹͶͲ
The group of non-typeable isolates with a best hit to the O11 serogroup were ʹͶͳ
analyzed separately to identify the reason for the lack of typeability. Of the 15 O11 ʹͶʹ
serogroup isolates, nine had an OSA coverage of 14.94-15.84% (Supplementary ʹͶ͵
Table 2); these corresponded to the presence of only the two flanking genes ʹͶͶ
himD/ihfB and wbpM. This observation shows that a best hit of a non-typeable ʹͶͷ
isolate to the O11 OSA cluster with a coverage of ~15% is the result of a complete ʹͶ͸
absence of an OSA cluster but the presence of the flanking genes. Two other isolates ʹͶ͹
had an OSA coverage of <2%, and corresponded to the absence of the entire OSA ʹͶͺ
cluster as well as the flanking genes (Supplementary table 2). In summary, a total of ʹͶͻ
11 of the 27 non-typeable isolates (or 11 of 1649 isolates analyzed in total) were ʹͷͲ
non-typeable due to a lack of the OSA cluster sequences.  ʹͷͳ
 ʹͷʹ
Genome mis-assembly accounts for false non-typeability ʹͷ͵
Since the seven non-typeable isolates with the highest OSA coverage (80-95%) in ʹͷͶ
Figure 4 were all candidates for harboring complete and functioning OSA clusters, ʹͷͷ
we analyzed the cause of non-typeability in this group of isolates. For each of the ʹͷ͸
isolates, we examined whether there were mis-assembly or assembly gaps within ʹͷ͹
the OSA gene cluster; we also looked for the occurrence of insertion sequence (IS) ʹͷͺ
elements, which often cause gaps in de novo assembly. Indeed, five of the seven ʹͷͻ
isolates contained assembly gaps within their OSA cluster, which account for the ʹ͸Ͳ
observed lowered OSA coverage (Table 2). The remaining two isolates had no gaps ʹ͸ͳ
within their OSA sequence (Table 2). However, both of these isolates had a best type ʹ͸ʹ
hit to the O11 serogroup, which is known to contain OSA sequences of both the O11 ʹ͸͵
and the O17 serotypes (16) (Table 1). Interestingly, the OSA cluster in these two ʹ͸Ͷ
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serotypes differ only by the presence of two IS elements and a deletion in the O17 ʹ͸ͷ
serotype OSA sequence (16). Alignment of the OSA sequence from the two non-ʹ͸͸
typable isolates to the O11 and O17 reference OSA sequences, respectively, ʹ͸͹
contained an O17 OSA gene cluster, which had been misassembled into ʹ͸ͺ
concatenated O11 serotype OSA clusters because of the O17 IS elements.  ʹ͸ͻ
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 ͳʹ
Discussion ʹ͹Ͳ
 ʹ͹ͳ
The serotyping technique has been one of the standard tools for epidemiological ʹ͹ʹ
studies and infection controls for many decades. The available historical records of P. ʹ͹͵
aeruginosa serotypes offer a vast amount of information about P. aeruginosa ʹ͹Ͷ
epidemiology and population structures (27–30). Although problems with non-ʹ͹ͷ
typeable isolates have been described since the implementation of the method, the ʹ͹͸
serotype information is still applicable today for outbreak tracking, strain typing, and ʹ͹͹
studies of LPS structure and evolution. The present study presents a newly ʹ͹ͺ
developed Web Server tool called PAst, which is user friendly, reliable, and high-ʹ͹ͻ
throughput for in silico serotyping of P. aeruginosa isolates.  ʹͺͲ
 ʹͺͳ
In contrast to conventional serology-based in vitro serotyping, PAst in silico ʹͺʹ
serotyping has a very low occurrence of non-typeablility. Of the 1649 analyzed ʹͺ͵
genomes, only 27 non-typeable isolates were detected across two separate P. ʹͺͶ
aeruginosa datasets. One dataset represents all available whole genome assemblies ʹͺͷ
of P. aeruginosa, while the other specifically represents genomes from CF infections, ʹͺ͸
which are known to contain high occurrences of non-typeability due to adaptability ʹͺ͹
of the bacteria into a biofilm life-style associated with chronicity of the infection (Fig. ʹͺͺ
1 and 2). Importantly, since the frequency of non-typeability of in vitro serotyped P. ʹͺͻ
aeruginosa isolates may amount to over 65% (10), analysis with PAst is clearly ʹͻͲ
advantageous and superior compared to conventional in vitro serotyping. ʹͻͳ
Importantly, the superiority of the PAst tool as a reliable and fast typing method is ʹͻʹ
consistent with other published tools for in silico serotyping (31–35). Similar to both ʹͻ͵
the SerotypeFinder (in silico serotyping of E. coli (31)), LisSero (in silico serotyping of ʹͻͶ
Listeria monocytogenes (34, 35)) and SeqSero (in silico serotyping of Salmonella (32)) ʹͻͷ
PAst resolves the OSA cluster information to the most accurate typing possible as a ʹͻ͸
serogroup representing 1-3 serotypes.  ʹͻ͹
 ʹͻͺ
Interestingly, we observed a high level of conservation of the OSA gene cluster ʹͻͻ
within the P. aeruginosa genome. In contrast to certain well-documented difficulties ͵ͲͲ
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in serology-based in vitro serotyping, PAst identified complete OSA clusters (with ͵Ͳͳ
>95% sequence being present) in 99.27% of the analyzed genomes. As such only 12 ͵Ͳʹ
of the 1649 isolates examined were found to be devoid of the OSA cluster and an ͵Ͳ͵
additional 8 isolates were found to contain only a partial OSA cluster in their ͵ͲͶ
genomes (<80% OSA sequence compared to the reference). These findings indicate ͵Ͳͷ
that the loss of typeability of P. aeruginosa isolates during the course of infection is ͵Ͳ͸
either due to mutations (rather than larger deletions) or is linked to other parts of ͵Ͳ͹
the LPS biosynthesis, such as regulatory genes or transport of the structure to the ͵Ͳͺ
cell surface. A study by Bélanger et al. reported that mutation in any of the four wbp ͵Ͳͻ
genes (wbpO, wbpP, wbpV and wbpM) in the OSA gene cluster could disrupt the P. ͵ͳͲ
aeruginosa O6 OSA biosynthesis (36). Furthermore, key genes involved in the OSA ͵ͳͳ
assembly and translocation through the Wzx/Wzy-dependent pathway not localized ͵ͳʹ
within the OSA cluster, for instance, waaL, are essential for O-antigen expression ͵ͳ͵
(37, 38). It is possible that more OSA-related genes might be present in the P. ͵ͳͶ
aeruginosa genomes, which have not been discovered yet. Overall, our study ͵ͳͷ
demonstrates that a complete lack of an OSA gene cluster is a rarely observed ͵ͳ͸
phenomenon in P. aeruginosa.  ͵ͳ͹
 ͵ͳͺ
PAst will enable further investigations of the diversity, evolution and variability of ͵ͳͻ
the OSA clusters. For example, the sequence of the cluster is part of the output ͵ʹͲ
material from the in silico serotyping which can then be readily analyzed for ͵ʹͳ
sequence variations to provide new knowledge on the mechanisms behind loss of ͵ʹʹ
typeability in vitro and in silico. Furthermore, PAst will enable systematic analysis of ͵ʹ͵
serotype switching by horizontal gene transfer and genetic recombination of the ͵ʹͶ
OSA gene cluster among different clone types. This recently described phenomenon ͵ʹͷ
has contributed to the evolution of the multi-drug resistant P. aeruginosa serotype ͵ʹ͸
O12 population that has successfully disseminated across hospitals worldwide (14). ͵ʹ͹
It is currently unknown if there are additional cases of such serotype switching by ͵ʹͺ
recombination.    ͵ʹͻ
 ͵͵Ͳ
The new PAst Web Server tool makes in silico serotyping of P. aeruginosa using WGS ͵͵ͳ
data a fast and reliable method. The use of PAst can play an important role in future ͵͵ʹ
 on June 6, 2016 by TECH KNOW
LEDGE CTR OF DENM
ARK
http://jcm
.asm
.org/
Downloaded from
 
 ͳͶ
surveillance of LPS evolution and possible outbreak detection. With the emergence ͵͵͵
of rapidly disseminating, high-risk clones of P. aeruginosa, such as the O12 ST111 ͵͵Ͷ
clone, new and reliable typing techniques for improved monitoring and tracking of ͵͵ͷ
such outbreaks are becoming increasingly important (13). With the lowered cost of ͵͵͸
sequencing and the increased focus on WGS of pathogens in clinics and hospital ͵͵͹
settings, genomics-based tools can assist in designing future treatments and ͵͵ͺ
containment of outbreaks.  ͵͵ͻ
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Figure legends Ͷͺ͸
FIG 1 Workflow illustrating the in silico serotyping of the Pseudomonas aeruginosa Ͷͺ͹
serotyper (PAst). Ͷͺͺ
 Ͷͺͻ
FIG 2 The distribution of the different serogroups (in %) identified via in silico ͶͻͲ
serotyping of the P. aeruginosa dataset using PAst. The analysis is based on all Ͷͻͳ
available P. aeruginosa genomes assemblies (n = 1120). Ͷͻʹ
 Ͷͻ͵
FIG 3 The distribution of the different serogroups (in %) identified via in silico ͶͻͶ
serotyping of CF specific P. aeruginosa isolates (n = 529) using PAst.  Ͷͻͷ
 Ͷͻ͸
FIG 4 Best-hit serotype distribution of the 27 non-typeable isolates as a function of Ͷͻ͹
the OSA coverage. Ͷͻͺ
  Ͷͻͻ
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Tables ͷͲͲ
TABLE 1 Serogroup definition in the PAst OSA database. 
Serogroup Reference OSA cluster Ref. gene Size (bp) Serotypes within serogroup 
O1 O1 18.368 O1 
O2 O2 wzyɴ 23.303 O2, O16 
O3 O3 20.210 O3, O15 
O5 O2 23.303 O5, O18, O20 
O4 O4 15.279 O4 
O6 O6 15.649 O6 
O7 O7 19.617 O7, O8 
O9 O9 17.263 O9 
O10 O10 17.635 O10, O19 
O11 O11 13.868 O11, O17 
O12 O12 25.864 O12 
O13 O13 14.316 O13, O14 
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TABLE 2 Non-typeable P. aeruginosa isolates with %OSA coverage of 80-95% with 
specification of assemblies. 
Strain Size (Mb) Scaffolds %GC Best hit %OSA wbpM himD Gap 
P. aeruginosa E2 635.733 196 66.4 O7 83.31 + + + 
P. aeruginosa IGB83 648.065 249 66.4 O2 84.46 + + + 
P. aeruginosa VRFPA04 681.803 1 66.5 O11 86.96 + + - 
P. aeruginosa 627.851 176 66.1 O6 90.54 + + + 
P. aeruginosa 148 664.374 128 66.1 O11 90.93 + + - 
P. aeruginosa ID4365 677.663 172 66.1 O7 91.74 + + + 
P. aeruginosa C2773C 671.772 200 65.9 O6 93.96 + + + 
 ͷͲʹ
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